Skip to Main Content

Author Details

Ted M Dawson
Johns Hopkins University School of Medicine
1983
523
151
PMIDPaper TitleJournal TitlePublished Year
37398476Exploring [<sup>11</sup>C]CPPC as a CSF1R-targeted PET Imaging Marker for Early Parkinson's Disease Severity.medRxiv2024
37398476Exploring [<sup>11</sup>C]CPPC as a CSF1R-targeted PET Imaging Marker for Early Parkinson's Disease Severity.medRxiv2024
36423813Mass Spectrometry-Based Proteomics Analysis of Human Substantia Nigra From Parkinson's Disease Patients Identifies Multiple Pathways Potentially Involved in the Disease.Mol Cell Proteomics2023
36423813Mass Spectrometry-Based Proteomics Analysis of Human Substantia Nigra From Parkinson's Disease Patients Identifies Multiple Pathways Potentially Involved in the Disease.Mol Cell Proteomics2023
38019930Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson's disease.Sci Transl Med2023
37647389Farnesol prevents aging-related muscle weakness in mice through enhanced farnesylation of Parkin-interacting substrate.Sci Transl Med2023
38071218Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide.Nat Commun2023
37870275PARIS undergoes liquid-liquid phase separation and poly(ADP-ribose)-mediated solidification.EMBO Rep2023
36652533The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease.Sci Transl Med2023
37271043Corrigendum for "Mass Spectrometry-Based Proteomics Analysis of Human Substantia Nigra From Parkinson's Disease Patients Identifies Multiple Pathways Potentially Involved in the Disease".Mol Cell Proteomics2023
36710687DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson's Disease.J Parkinsons Dis2023
36626371Atp7b-dependent choroid plexus dysfunction causes transient copper deficit and metabolic changes in the developing mouse brain.PLoS Genet2023
37425943Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PINK1-deficient Human Dopamine Neurons.bioRxiv2023
37296356The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives.Neurotherapeutics2023
37293032Pathological Tau transmission initiated by binding lymphocyte-activation gene 3.bioRxiv2023
37100955Apoptotic cell death in disease-Current understanding of the NCCD 2023.Cell Death Differ2023
36724785Bi-allelic TTI1 variants cause an autosomal-recessive neurodevelopmental disorder with microcephaly.Am J Hum Genet2023
38019930Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson's disease.Sci Transl Med2023
38071218Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide.Nat Commun2023
37647389Farnesol prevents aging-related muscle weakness in mice through enhanced farnesylation of Parkin-interacting substrate.Sci Transl Med2023
37870275PARIS undergoes liquid-liquid phase separation and poly(ADP-ribose)-mediated solidification.EMBO Rep2023
37425943Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PINK1-deficient Human Dopamine Neurons.bioRxiv2023
37271043Corrigendum for "Mass Spectrometry-Based Proteomics Analysis of Human Substantia Nigra From Parkinson's Disease Patients Identifies Multiple Pathways Potentially Involved in the Disease".Mol Cell Proteomics2023
37100955Apoptotic cell death in disease-Current understanding of the NCCD 2023.Cell Death Differ2023
37296356The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives.Neurotherapeutics2023
37293032Pathological Tau transmission initiated by binding lymphocyte-activation gene 3.bioRxiv2023
36724785Bi-allelic TTI1 variants cause an autosomal-recessive neurodevelopmental disorder with microcephaly.Am J Hum Genet2023
36626371Atp7b-dependent choroid plexus dysfunction causes transient copper deficit and metabolic changes in the developing mouse brain.PLoS Genet2023
36652533The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease.Sci Transl Med2023
36710687DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson's Disease.J Parkinsons Dis2023
34323016ADP-ribosyltransferases, an update on function and nomenclature.FEBS J2022
35394877STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy.Proc Natl Acad Sci U S A2022
36044549Amelioration of pathologic α-synuclein-induced Parkinson's disease by irisin.Proc Natl Acad Sci U S A2022
35654037Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.Neuron2022
35521944Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease.Mov Disord2022
36103513Poly(ADP-ribose) promotes toxicity of <i>C9ORF72</i> arginine-rich dipeptide repeat proteins.Sci Transl Med2022
36354133Mass spectrometry-based proteomics analysis of human globus pallidus from progressive supranuclear palsy patients discovers multiple disease pathways.Clin Transl Med2022
36280265The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgA[D257A/D257A] Mitochondrial Mutator Mice.J Neurosci2022
35363524Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson's disease.Sci Adv2022
35412917A high-affinity cocaine binding site associated with the brain acid soluble protein 1.Proc Natl Acad Sci U S A2022
36125899Pharmacologic inhibition of MIF nuclease: A new treatment paradigm to treat cell death.Clin Transl Med2022
35545089PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson's disease.Cell2022
36438964APDM gait and balance measures fail to predict symptom progression rate in Parkinson's disease.Front Neurol2022
36378485Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson's Disease.CNS Drugs2022
35977929AAAâ¿¿+â¿¿ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1.Nat Commun2022
34247782CYFIP1 Dosages Exhibit Divergent Behavioral Impact via Diametric Regulation of NMDA Receptor Complex Translation in Mouse Models of Psychiatric Disorders.Biol Psychiatry2022
34323016ADP-ribosyltransferases, an update on function and nomenclature.FEBS J2022
34744054Waiting for PARIS-A Biological Target in Search of a Drug.J Parkinsons Dis2022
35310936Prevention and regression of megamitochondria and steatosis by blocking mitochondrial fusion in the liver.iScience2022
35172141Interleukin-6 triggers toxic neuronal iron sequestration in response to pathological α-synuclein.Cell Rep2022
  • 1 - 50 of 1,046

Recommended Authors

Department of Psychiatry and McLean Hospital, Harvard Medical School
Career Start Year 2014
Number of shared co-authors 1
University College London, UK Dementia Research Institute
Career Start Year 2013
Number of shared co-authors 11
Tel Aviv University
Career Start Year 2010
Number of shared co-authors 4
The Scripps Research Institute
Career Start Year 2010
Number of shared co-authors 4
Institute of Medical Genetics and Applied Genomics, University of Tubingen
Career Start Year 2007
Number of shared co-authors 5
Neurodegenerative Diseases Research Unit
Career Start Year 2006
Number of shared co-authors 0
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2005
Number of shared co-authors 6
Pfizer Neuroscience and Pain Research Unit, Pfizer Ltd.
Career Start Year 2004
Number of shared co-authors 0
Sean M. Healey & AMG Center for ALS at Mass General
Career Start Year 2003
Number of shared co-authors 3
University of Miami Miller School of Medicine
Career Start Year 2003
Number of shared co-authors 0
College of Animal Science and Technology, Huazhong Agricultural University
Career Start Year 2002
Number of shared co-authors 0
University of Manitoba
Career Start Year 2000
Number of shared co-authors 0
Helen and Robert Appel Alzheimer's Disease Research Institute
Career Start Year 1999
Number of shared co-authors 12
University of Leicester
Career Start Year 1992
Number of shared co-authors 2
McLean Hospital and Program in Neuroscience, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 2
University of California san francisco
Career Start Year 1990
Number of shared co-authors 13
University of Arkansas for Medical Sciences
Career Start Year 1989
Number of shared co-authors 1
Garrison Institute on Aging, Texas Tech University Health Sciences Center
Career Start Year 1989
Number of shared co-authors 1
University of Washington School of Medicine
Career Start Year 1988
Number of shared co-authors 13
Tufts Medical Center and Neuroscience, Tufts University
Career Start Year 1987
Number of shared co-authors 13
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 1987
Number of shared co-authors 19
Boston University Chobanian & Avedisian School of Medicine
Career Start Year 1985
Number of shared co-authors 45
University of Brescia
Career Start Year 1985
Number of shared co-authors 2
Keck School of Medicine, University of Southern California
Career Start Year 1985
Number of shared co-authors 0
Sheffield Institute for Translational Neuroscience, University of Sheffield
Career Start Year 1983
Number of shared co-authors 29
Georgetown University
Career Start Year 1981
Number of shared co-authors 17
ASU-Banner Neurodegenerative Disease Research Center, Arizona State University
Career Start Year 1981
Number of shared co-authors 15
Inc. University Avenue
Career Start Year 1980
Number of shared co-authors 8
Abigail Wexner Research Institute, Nationwide Children's Hospital
Career Start Year 1976
Number of shared co-authors 4
University of California San Diego
Career Start Year 1973
Number of shared co-authors 10

Collaborators

Institute for Cell Engineering, Johns Hopkins University School of Medicine
Co-authored papers 366
Co-authored papers 61
Co-authored papers 45
Co-authored papers 32
Mayo Clinic Jacksonville
Co-authored papers 12
Lou Ruvo Center for Brain Health, Cleveland Clinic Nevada
Co-authored papers 11
Institute for Cell Engineering, Johns Hopkins University School of Medicine
Co-authored papers 10
University of Pennsylvania
Co-authored papers 10
Johns Hopkins University School of Medicine
Co-authored papers 10
Center for Genomics and Transcriptomics (CeGaT)
Co-authored papers 9
Jungers Center for Neurosciences, Oregon Health and Science University
Co-authored papers 8
Co-authored papers 7
Co-authored papers 7
Stanford University
Co-authored papers 7
Lou Ruvo Center for Brain Health, Cleveland Clinic
Co-authored papers 7
University of Colorado
Co-authored papers 6
Indiana University School of Medicine
Co-authored papers 6
National Institute On Aging
Co-authored papers 6
National Institute on Aging
Co-authored papers 6
University of California
Co-authored papers 5
Oregon Health and Science University
Co-authored papers 5
Co-authored papers 5
New York State Psychiatric Institute, Research Foundation for Mental Hygiene
Co-authored papers 4
Mayo Clinic Rochester
Co-authored papers 4
Co-authored papers 4
Johns Hopkins University School of Medicine
Co-authored papers 4
Co-authored papers 4
Oncode Institute
Co-authored papers 4
The Scripps Research Institute, University of California
Co-authored papers 4
Instituto Universitario de Oncologia, Universidad de Oviedo
Co-authored papers 4